Nutrition containing fat blend

Details Nutrition containing fat blend Nutrition containing fat blend

2005-11-11

2011-11-08

Weddington, Kevin E (Department: 1629)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Ester doai

C514S558000, C514S559000, C514S560000

Reexamination Certificate

active

08053471

ABSTRACT:
The invention relates to the use of long chain polyunsaturated fatty acids for the manufacture of a nutritional composition for feeding infants of a mother who suffered from a metabolic disorder during pregnancy and to a corresponding composition. Said composition comprises a n-3 polyunsaturated fatty acid fraction containing at least 0.1 wt docosahexaenoic acid (DHA) based on total weight of the lipid, at least 0.01 wt % n-3 docosapentaenoic acid (DPAn-3) based on total weight of the lipid, and at least 0.01 wt. % eicosapentaenoic acid (EPA) based on total weight of the lipid, wherein the sum of DHA, DPAn-3 and EPA is below 1 wt. % of total lipid.

REFERENCES:
patent: 5886037 (1999-03-01), Klor et al.
patent: 0 484 266 (1992-05-01), None
patent: 0484266 (1992-05-01), None
patent: 0 775 449 (1997-05-01), None
patent: 0775449 (1997-05-01), None
patent: 0 823 475 (1998-02-01), None
patent: 0823475 (1998-02-01), None
patent: 1809125 (2010-02-01), None
patent: 9836745 (1998-08-01), None
patent: WO 98/36745 (1998-08-01), None
patent: 0020603 (2000-04-01), None
patent: WO 00/20603 (2000-04-01), None
patent: 0040705 (2000-07-01), None
patent: WO 00/40705 (2000-07-01), None
patent: 0178530 (2001-10-01), None
patent: WO 01/78530 (2001-10-01), None
patent: 02092540 (2002-11-01), None
patent: WO 02/092540 (2002-11-01), None
patent: 2004052115 (2004-06-01), None
patent: WO 2004/052115 (2004-06-01), None
Notice of Opposition to EP 1 809 125 filed on Dec. 28, 2010, in corresponding European Patent Application No. 05813382.8.
Product Label: Frisomel Advance 2—follow on milk, Dl, 2010.
Product Label: Frisolac Advance—infant milk, D2, 2010.
Product Label: Friso 1 Infant formula, D3, 2010.
Product packaging: Frisolac Advance Infant Milk Can, D4, 2010.
Table: Friso brand products, fatty acid composition thereof, D5, 2010.
Pestka, James J. et al., “Dietary Fish Oil Suppresses Experimental Immuniglobulin A Nephropathy in Mice,” Nutritional Immunology 132 (2002) 261-269, D6.
Koletzko, Berthold et al., “Physiological aspects of human milk lipids,” Early Human Development 65 Suppl. (2001) S3-S18, D7.
Ghebremeskel, Kebreab et al., “Type 1 Diabetes Compromises Plasma Arachidonic and Docosahexaenoic Acids in Newborn Babies,” Lipids 2004, 39(4), 335-342, D8.
Hansen, Harald S., “New Biological and Clinical Roles for the n-6 and n-3 Fatty Acids,” Nutrition Reviews, 52(5) 1994, 1620167, D9.
Wijendran, Vaduki et al., “Fetal Erythrocyte Phospholipid Polyunsaturated Fatty Acids Are Altered in Pregnancy Complicated with Gestational Diabetes Mellitus,” Lipids35(8) 2000, 927-931, D10.
Andersen, Steen et al., “Microencapsulated Marine Omega-3 Fatty Acids for Use in the Food Industry,” Food Tech Europe Dec. 1994/Jan. 1995, D11.
Carlson, Susan E. et al., “Effect of Fish Oil Supplementation on the n-3 Fatty Acid Content of Red Blood Cell Membranes in Pre-term Infants,” Pediatric Research, 21(5), 1987, D12.

Affiliated with

Also associated with

Rating

Nutrition containing fat blend does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nutrition containing fat blend, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nutrition containing fat blend will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4289507